MRI evidence of gray matter loss in COVID-19 patients with cognitive and olfactory disorders.

Serena Capelli Alberto ArrigoniAngela NapolitanoGiulio PezzettiAndrea RemuzziRosalia ZangariFerdinando Luca LoriniMaria SessaAnna CaroliSimonetta Gerevini

Published in: Annals of clinical and translational neurology (2024)

Our MRI findings show that COVID-19-related olfactory and cognitive disorders both induce GM atrophy, although at different degrees of severity, likely indicative of neurodegeneration and neuroinflammation.

Keyphrases

sars cov
contrast enhanced
magnetic resonance imaging
coronavirus disease
diffusion weighted imaging
traumatic brain injury
lipopolysaccharide induced
computed tomography
lps induced
respiratory syndrome coronavirus
inflammatory response
subarachnoid hemorrhage